| abstract |
The present invention relates to Flaviviridae (BVDV and HCV) in a host comprising animals, especially humans, using nucleosides of Formulas (I)-(II) or pharmaceutically acceptable salts or prodrugs thereof. , Orthomyxoviridae (Influenza A and B) or Paramyxoviridae (RSV) infection, or a composition for treating abnormalities associated with abnormal cell proliferation. The present invention also provides an effective method for measuring viral load, in particular BVDV, HCV or West Nile virus load, in a host using real time polymerase chain reaction ("TR-PCR"). In addition, the present invention discloses probe molecules capable of emitting light in proportion to the amount of virus present in the sample. |